Weekly Roundup: May 18, 2019

Weekly Roundup: May 18, 2019

This week, the team discuss the deal between UK's National Health Service and Biogen prompting the successful reimbursement of Biogen’s Spinraza as a treatment for spinal muscular atrophy and Solid Biosciences’ clinical update on its Duchenne Muscular Dystrophy gene therapy product SGT-001.   Presenter: Aparna Krishnan Contributor: Max Rex Producer: Aparna Krishnan

Duration: 7 min

Release Date:

Share part or all of the audio of this episode